Traditional Chinese medicine · Western herbalism
Rhubarb rootRheum palmatum; Rheum officinale
Rhubarb root (da huang) is a stimulant laxative; a 42-person trial used 12.5 or 25 mg of rhein a day for 30 days, while the EU monograph caps use at 1 week.
- Botanical name
- Rheum palmatum; Rheum officinale
- Part used
- root and rhizome, dried (not the edible stalk)
- Also called
- pinyin Da huang (大黄); Chinese rhubarb, Rhei radix, Rhei radix et rhizoma, Dai-o (Japanese)
- Used in
- Traditional Chinese medicine, Western herbalism
- Taken for
- Constipation, Liver and bile
- Sold as
- decoction, powder, tablets, granule extract, patent medicine, dried slices
What is meant by rhubarb root
Rhubarb root, or da huang in Chinese, is the dried root and rhizome of Rheum palmatum and R. officinale, and in China of the related R. tanguticum. It is not the edible garden rhubarb stalk. A review of the herb in the American Journal of Chinese Medicine says it is in the 2020 Chinese Pharmacopoeia, is one of the most commonly used Chinese medicines, and contains more than 170 compounds, with anthraquinones and anthrones as the major group, along with stilbenes, chromones, flavonoids and tannins.
The anthranoid compounds are what make it a laxative. The European monograph explains that the sennosides and related glycosides are not absorbed in the upper gut: bacteria in the large intestine convert them into active anthrones, which speed colonic movement and draw water and electrolytes into the bowel, with the bowel opening 8 to 12 hours later. The monograph classes it as a contact laxative. It is prepared raw, steamed with wine or charred, and is taken as a decoction, a powder, a granule extract, in tablets and in patent medicines.
In the traditions
Traditional Chinese medicine (about TCM)
Da huang is bitter and cold in the materia medica, entering the spleen, stomach, large intestine, liver and pericardium channels, with the actions of draining downward accumulations, clearing heat and draining fire, cooling blood, resolving toxicity and invigorating blood to dispel stasis. For the gut the tradition uses it for what it calls heat and dryness accumulated in the intestines: hard stools, abdominal fullness and pain, and feverishness, which is the picture Da Cheng Qi Tang is written for, where it is paired with mirabilite, magnolia bark and immature bitter orange. The same texts use it in damp-heat jaundice. Rhubarb meant for purging is conventionally cooked briefly or added near the end of a decoction. Heat and dryness in the intestines is the texts’ description and not a finding.
Western herbalism
Western herbal medicine knows rhubarb root as a stimulant laxative of the anthranoid group. The European Union herbal monograph, which refers to the European Pharmacopoeia monograph for the material, accepts it as a well-established-use herbal medicinal product for short-term use in cases of occasional constipation, standardized to hydroxyanthracene derivatives calculated as rhein. The monograph limits use to one week, tells users to try diet change or bulk-forming agents first, and contraindicates use in pregnancy, lactation and under 12 years.
What the plant contains
The laxative compounds are anthraquinones and anthrones, among them rhein, emodin and aloe-emodin, partly bound as glycosides of the sennoside type. After a dose, rhein, emodin and traces of chrysophanol appear in human urine, the EU monograph reports. In animal studies, a total anthraquinone extract caused kidney effects in rats at 4,500 mg per kg a day for 13 weeks, an ethanolic root extract was weakly mutagenic in one bacterial test, and several hydroxyanthracene derivatives were genotoxic in laboratory systems though not shown in living animals. These are laboratory and animal findings.
What has been tested in people
Rhubarb has real single-herb human data, unlike most of the herbs on this list, though the trials are small or from China.
For constipation, a double-blind, placebo-controlled trial randomized 42 middle-aged volunteers, 14 per group, to rhubarb extract delivering 12.5 or 25 mg of rhein a day, or placebo, for 30 days. Stool frequency and consistency, and perceived transit, improved in both extract groups compared with placebo, with a larger effect at the higher dose, and blood potassium did not change. The trial studied infrequent bowel movements and not severe constipation, and the sample was 95 percent women.
For pancreatitis and the bowel, Chinese trials use crude rhubarb as an add-on. A meta-analysis of 19 trials with 1,161 patients found that adding crude rhubarb to somatostatin cut total complications (RR 0.55, 95% CI 0.41 to 0.73) and hospital stay (6.70 days shorter), with no significant difference in mortality (RR 0.61, 0.34 to 1.12); a second pooled 16 trials in 912 people with severe disease, and the authors warned of publication bias. In ulcerative colitis, a meta-analysis of 30 studies with 2,475 patients found rhubarb-based therapy, oral or by enema, improved efficacy and recurrence, pooling studies of mixed design; note that the EU monograph contraindicates oral rhubarb in ulcerative colitis, a different context from these trials. Da Cheng Qi Tang, which contains rhubarb, is covered on the magnolia bark page.
Not tested: rhubarb against standard laxatives, long-term outcomes, and any use in children.
| Study | Dose | What it found |
|---|---|---|
| Double-blind placebo-controlled RCT, 42 randomized middle-aged adults with infrequent bowel movements (rhubarb extract) PMID 36499011 | Extract giving 12.5 or 25 mg of rhein a day for 30 days | Stool frequency and consistency better than placebo in both doses; blood potassium unchanged |
| Meta-analysis of 19 RCTs, 1,161 patients with acute pancreatitis (crude rhubarb added to somatostatin) PMID 27693773 | Crude rhubarb as add-on | Complications RR 0.55 (0.41 to 0.73); hospital stay 6.70 days shorter; mortality RR 0.61 (0.34 to 1.12), not significant |
| Meta-analysis of 16 RCTs, 912 patients with severe acute pancreatitis (rhubarb plus trypsin inhibitor) PMID 29672966 | Rhubarb added to standard care | Lower mortality, shorter hospital stay and pain relief time; publication bias noted; no serious adverse events |
| Meta-analysis of 30 studies, 2,475 patients with ulcerative colitis (rhubarb-based therapy, oral or enema) PMID 36339579 | Oral or enema; course length varied by study | Higher efficacy and lower recurrence; better than 5-ASA or sulfasalazine alone; no significant side effects reported |
| Meta-analysis of 60 RCTs, 6,095 patients with intestinal obstruction (Da Cheng Qi Tang, contains rhubarb) PMID 25392589 | Decoction, alone or added to conservative therapy | Add-on response RR 1.25 (1.20 to 1.30); time to first flatus SMD -2.09 |
Doses used in trials and traditional preparations
The EU monograph gives a preparation equivalent to 20 to 30 mg of hydroxyanthracene derivatives, calculated as rhein, once a day at night, as the smallest dose that gives a soft stool, or a tea of not more than 30 mg in 150 ml of boiling water, and no more than one week of use. The 42-person trial used 12.5 or 25 mg of rhein a day for 30 days, which is longer than the monograph allows. The traditional decoction is dosed in grams of the root and differs by formula; purgative use is a short cook or a late addition. In the pancreatitis trials the crude root was given as an add-on to standard treatment in hospital.
Treat these figures as a record of what was studied. Whether any amount of rhubarb root suits a particular person is a question for a clinician or pharmacist who knows their history.
Safety
The EU monograph lists abdominal pain, spasm and liquid stools as the common effects, pseudomelanosis coli (pigment in the bowel lining, which recedes after stopping) with chronic use, yellow or red-brown urine, and, after long use, water and electrolyte loss that may cause protein or blood in the urine. Overdose causes griping pain and severe diarrhea with loss of fluid and potassium; chronic overdose of anthranoid products may lead to toxic hepatitis. It contraindicates use in pregnancy, lactation, under 12, intestinal obstruction, appendicitis, inflammatory bowel disease, abdominal pain of unknown origin and severe dehydration. In rats, total rhubarb anthraquinones damaged the kidney at the highest dose (4,500 mg per kg for 13 weeks), and the monograph reports no further toxicology data for the root itself.
Drug interactions
The mechanism is potassium. The EU monograph says low potassium from long-term laxative use strengthens the action of cardiac glycosides and interacts with antiarrhythmic medicines, and that concomitant use with diuretics, corticosteroids and liquorice root may increase potassium loss. It tells patients taking cardiac glycosides, antiarrhythmics, QT-prolonging medicines, diuretics, corticosteroids or liquorice to consult a doctor before taking rhubarb, and notes that people with kidney disorders should be aware of possible electrolyte imbalance. The 42-person trial found no change in potassium over 30 days at either dose.
Want to know which products fit your symptoms?
Answer a few questions about your symptoms, routine and medicines, and the quiz names one product, with the reasons it won.
Take the quizRelated herbs
Questions people ask
Is rhubarb root the same as garden rhubarb?
No. The medicinal drug is the dried root and rhizome of Rheum palmatum or R. officinale, not the edible stalk.
How does rhubarb root work as a laxative?
Its sennoside-type glycosides pass through the upper gut unabsorbed. Bacteria in the colon convert them to active anthrones, which speed transit and draw in water and electrolytes, with a bowel movement after about 8 to 12 hours.
How long is it meant to be used?
The European Union monograph limits use to one week and says to try diet change or bulk-forming agents first. The 42-person trial used 30 days at 12.5 or 25 mg of rhein a day.
Does rhubarb help acute pancreatitis?
A meta-analysis of 19 trials with 1,161 patients found fewer complications and shorter hospital stay when crude rhubarb was added to somatostatin, with no significant difference in mortality. The trials had methodological flaws.
Who is told to avoid it?
The monograph contraindicates use in pregnancy, lactation, children under 12, bowel obstruction, appendicitis, Crohn’s disease and ulcerative colitis, and severe dehydration. It also flags heart medicines and diuretics.
Sources
- Neyrinck AM et al., "Constipation Mitigation by Rhubarb Extract in Middle-Aged Adults Is Linked to Gut Microbiome Modulation: A Double-Blind Randomized Placebo-Controlled Trial", Int J Mol Sci 2022;23:14685 pubmed.ncbi.nlm.nih.gov/36499011
- Zhou Y et al., "Add-on effect of crude rhubarb to somatostatin for acute pancreatitis: A meta-analysis of randomized controlled trials", J Ethnopharmacol 2016;194:495-505 pubmed.ncbi.nlm.nih.gov/27693773
- Hu J, Li P, Zhang T, "Rhubarb combined with trypsin inhibitor for severe acute pancreatitis: A systematic review and meta-analysis", Phytother Res 2018;32:1450-8 pubmed.ncbi.nlm.nih.gov/29672966
- Li Y et al., "The application of Tong-fu therapeutic method on ulcerative colitis: A systematic review and meta-analysis for efficacy and safety of rhubarb-based therapy", Front Pharmacol 2022;13:1036593 pubmed.ncbi.nlm.nih.gov/36339579
- Yang B et al., "Da-cheng-qi decoction, a traditional Chinese herbal formula, for intestinal obstruction: systematic review and meta-analysis", Afr J Tradit Complement Altern Med 2014;11:101-19 pubmed.ncbi.nlm.nih.gov/25392589
- Xu H et al., "Botany, Traditional Use, Phytochemistry, Pharmacology and Clinical Applications of Rhubarb (Rhei Radix et Rhizome): A Systematic Review", Am J Chin Med 2024;52:1925-67 pubmed.ncbi.nlm.nih.gov/39558546
- European Medicines Agency, European Union herbal monograph on Rheum palmatum L. and Rheum officinale Baillon, radix, Final - Revision 1 (EMA/HMPC/113700/2019) ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-rheum-palmatum-l-rheum-officinale-baillon-radix-revision-1_en.pdf
- Bensky D, Clavey S, Stoger E, Chinese Herbal Medicine: Materia Medica, 3rd ed., Eastland Press, 2004 (nature, flavor, channels and actions as the tradition gives them) www.eastlandpress.com/products/chinese-herbal-medicine-materia-medica-portable-3rd-ed
- Bensky D, Barolet R, Ellis A, Scheid V, Chinese Herbal Medicine: Formulas and Strategies, 2nd ed., Eastland Press, 2009 (Da Cheng Qi Tang composition) www.eastlandpress.com/products/chinese-herbal-medicine-formulas-strategies-portable-2nd-edition